The Lexington, MA-based contrast agent developer has named Elkan Gamzu, Ph.D., as interim CEO, effective immediately. Gamzu is currently a consultant to the biotechnology and pharmaceutical industries, Epix said.
Epix wins South Korean approval of Vasovist, July 10, 2008
Epix resubmits Vasovist NDA, July 1, 2008
Epix president resigns, May 29, 2008
Epix to resubmit NDA for Vasovist, April 24, 2008
Epix reaches agreement with FDA over Vasovist, February 1, 2008
Copyright © 2008 AuntMinnie.com